Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca

Article

Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Related Content
Guiding ob-gyns back to evidence-based care | Image Credit: © Iryna - stock.adobe.com.

Guiding ob-gyns back to evidence-based care

Brian K. Iriye, MD;James D. Keller, MD, MHSA
May 23rd 2025
Article

A thoughtful approach to behavioral change.

Read More

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Celeste Krewson, Assistant Editor
December 31st 2024
Podcast

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

Contemporary OB/GYN week in review: ACOG 2025, prenatal diabetes, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: ACOG 2025, prenatal diabetes, and more

Celeste Krewson, Assistant Editor
May 23rd 2025
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Angie Lee, MD, FACOG, executive medical director for Women’s Healthcare at Bayer U.S. Medical Affairs

Angie Lee, MD, FACOG, discusses bridging the menopause care gap

Angie Lee, MD, FACOG
May 22nd 2025
Article

Angie Lee, MD, FACOG, discusses how clinicians can bridge the gap in menopause care to ensure better outcomes for their patients.

Read More

Study finds biologic use drops during pregnancy in autoimmune patients | Image Credit: © Subbotina Anna - © Subbotina Anna - stock.adobe.com.

Study finds biologic use drops during pregnancy in autoimmune patients

Celeste Krewson, Assistant Editor
May 22nd 2025
Article

A study found that biologic treatment rates decline during pregnancy and only partially rebound postpartum, with trends varying by autoimmune condition.

Read More

© 2025 MJH Life Sciences

All rights reserved.